ATE427958T1 - Gm-negative ehv-mutante ohne heterologe elementen - Google Patents

Gm-negative ehv-mutante ohne heterologe elementen

Info

Publication number
ATE427958T1
ATE427958T1 AT03765007T AT03765007T ATE427958T1 AT E427958 T1 ATE427958 T1 AT E427958T1 AT 03765007 T AT03765007 T AT 03765007T AT 03765007 T AT03765007 T AT 03765007T AT E427958 T1 ATE427958 T1 AT E427958T1
Authority
AT
Austria
Prior art keywords
elements
ehv
heterologue
viruses
negative ehv
Prior art date
Application number
AT03765007T
Other languages
English (en)
Inventor
Antonie Neubauer
Christina Ziegler
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Application granted granted Critical
Publication of ATE427958T1 publication Critical patent/ATE427958T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03765007T 2002-07-19 2003-07-16 Gm-negative ehv-mutante ohne heterologe elementen ATE427958T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2002133064 DE10233064A1 (de) 2002-07-19 2002-07-19 gM-negative EHV-Mutanten ohne heterologe Elemente

Publications (1)

Publication Number Publication Date
ATE427958T1 true ATE427958T1 (de) 2009-04-15

Family

ID=30010261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03765007T ATE427958T1 (de) 2002-07-19 2003-07-16 Gm-negative ehv-mutante ohne heterologe elementen

Country Status (17)

Country Link
EP (1) EP1539808B1 (de)
JP (2) JP4688491B2 (de)
KR (2) KR101111998B1 (de)
CN (4) CN101711864A (de)
AT (1) ATE427958T1 (de)
AU (1) AU2003258517B2 (de)
BR (1) BR0312787A (de)
CA (1) CA2493406C (de)
CY (1) CY1109206T1 (de)
DE (2) DE10233064A1 (de)
DK (1) DK1539808T3 (de)
ES (1) ES2324406T3 (de)
MX (1) MXPA05000592A (de)
PL (1) PL208225B1 (de)
PT (1) PT1539808E (de)
SI (1) SI1539808T1 (de)
WO (1) WO2004009802A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1129722A1 (de) 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten
AR040601A1 (es) 2002-07-19 2005-04-13 Boehringer Ingelheim Vetmed Mutantes ehv negativos de gm sin elementos heterologos
CN101926560A (zh) * 2010-08-31 2010-12-29 苏州星岛金属制品有限公司 可伸缩的凳子
NZ751966A (en) * 2016-09-20 2023-03-31 Boehringer Ingelheim Vetmedica Gmbh New promoters
US20250114447A1 (en) 2021-08-06 2025-04-10 Intervet Inc. Vaccine for equine herpesvirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6193983B1 (en) * 1992-06-01 2001-02-27 The University Of Melbourne Equine herpesvirus glycoproteins
EP1129722A1 (de) * 2000-02-17 2001-09-05 Boehringer Ingelheim Vetmedica Gmbh GM-negative EHV Mutanten

Also Published As

Publication number Publication date
DE10233064A1 (de) 2004-02-05
CN101711864A (zh) 2010-05-26
CA2493406C (en) 2013-02-26
AU2003258517B2 (en) 2009-05-07
EP1539808A2 (de) 2005-06-15
WO2004009802A2 (en) 2004-01-29
JP2010057512A (ja) 2010-03-18
WO2004009802A3 (en) 2005-04-21
DK1539808T3 (da) 2009-07-27
CY1109206T1 (el) 2014-07-02
CN101712949A (zh) 2010-05-26
BR0312787A (pt) 2005-05-03
PL374574A1 (en) 2005-10-31
CN1668736A (zh) 2005-09-14
CN101712949B (zh) 2013-07-03
KR101111998B1 (ko) 2012-02-15
MXPA05000592A (es) 2005-04-28
JP5469444B2 (ja) 2014-04-16
CA2493406A1 (en) 2004-01-29
KR101167576B1 (ko) 2012-08-01
DE60327082D1 (de) 2009-05-20
SI1539808T1 (sl) 2009-08-31
PT1539808E (pt) 2009-05-21
CN102978168A (zh) 2013-03-20
JP2005532819A (ja) 2005-11-04
EP1539808B1 (de) 2009-04-08
ES2324406T3 (es) 2009-08-06
JP4688491B2 (ja) 2011-05-25
PL208225B1 (pl) 2011-04-29
AU2003258517A1 (en) 2004-02-09
KR20050055689A (ko) 2005-06-13
KR20110007629A (ko) 2011-01-24

Similar Documents

Publication Publication Date Title
MXPA05005202A (es) Vacuna.
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
DE69736984D1 (de) Inhibitoren des interleukin-1-beta konvertierenden enzyms
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
DE60323133D1 (de) Cyclohexylverbindungen als ccr5-antagonisten
DK0652228T3 (da) Urethaner og urinstoffer, som fremkalder cytoproduktion
DE69732712D1 (de) INHIBITOREN DES INTERLEUKIN-1beta KONVERTIERENDEN ENZYMS
DE60221539D1 (de) Verfahren und zusammensetzungen zur kontrolle von coccidiose
BR0306922A (pt) N-pirazinil-fenilsulfonamidas e seu uso no tratamento de doenças mediadas por quimocina
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
DE69925581D1 (de) 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
CY1109206T1 (el) gM- ΑΡΝΗΤΙΚΟΙ EHV-ΜΕΤΑΛΛΑΚΤΕΣ ΧΩΡΙΣ ΕΤΕΡΟΛΟΓΑ ΣΤΟΙΧΕΙΑ
AR040601A1 (es) Mutantes ehv negativos de gm sin elementos heterologos
DE60325838D1 (de) Imidazoquinolinamine als adjuvantien für hiv dna vakzine
CY1109023T1 (el) Gm-αρνητικα μεταλλαγματα ehv
AR042019A1 (es) N-acetilgalactosamina-4-sulfatasa precursora, composiciones farmaceuticas que la contienen , metodos de tratamiento que la utilizan y metodos para producirla y purificarla
ATE469657T1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
MA27474A1 (fr) Vaccin
ATE295838T1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
WO2002081712A3 (en) Artificial chromosomes comprising ehv sequences
SE0002498D0 (sv) Papillomavirus vaccine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1539808

Country of ref document: EP